Emerging Developments in Management of Melanoma During the COVID-19 Era

In March 2020, the designation of the COVID-19 outbreak as a worldwide pandemic marked the beginning of an unprecedented era in modern medicine. Facing the possibility of resource precincts and healthcare rationing, leading dermatological and cancer societies acted expeditiously to adapt their guide...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Andraia R. Li, Manuel Valdebran, Daniel Y. Reuben
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	melanoma coronavirus SARS-CoV-2 malignant melanoma COVID-19 Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/ab083738755c4270a22fb8449d46d714
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ab083738755c4270a22fb8449d46d714
record_format	dspace
spelling	oai:doaj.org-article:ab083738755c4270a22fb8449d46d7142021-11-08T06:23:40ZEmerging Developments in Management of Melanoma During the COVID-19 Era2296-858X10.3389/fmed.2021.769368https://doaj.org/article/ab083738755c4270a22fb8449d46d7142021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.769368/fullhttps://doaj.org/toc/2296-858XIn March 2020, the designation of the COVID-19 outbreak as a worldwide pandemic marked the beginning of an unprecedented era in modern medicine. Facing the possibility of resource precincts and healthcare rationing, leading dermatological and cancer societies acted expeditiously to adapt their guidelines to these contingencies. Melanoma is a lethal and aggressive skin cancer necessitating a multidisciplinary approach to management and is associated with significant healthcare and economic cost in later stages of disease. In revisiting how the pandemic transformed guidelines from diagnosis and surveillance to surgical and systemic management of melanoma, we appraise the evidence behind these decisions and their enduring implications.Andraia R. LiManuel ValdebranManuel ValdebranDaniel Y. ReubenFrontiers Media S.A.articlemelanomacoronavirusSARS-CoV-2malignant melanomaCOVID-19Medicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	melanoma coronavirus SARS-CoV-2 malignant melanoma COVID-19 Medicine (General) R5-920
spellingShingle	melanoma coronavirus SARS-CoV-2 malignant melanoma COVID-19 Medicine (General) R5-920 Andraia R. Li Manuel Valdebran Manuel Valdebran Daniel Y. Reuben Emerging Developments in Management of Melanoma During the COVID-19 Era
description	In March 2020, the designation of the COVID-19 outbreak as a worldwide pandemic marked the beginning of an unprecedented era in modern medicine. Facing the possibility of resource precincts and healthcare rationing, leading dermatological and cancer societies acted expeditiously to adapt their guidelines to these contingencies. Melanoma is a lethal and aggressive skin cancer necessitating a multidisciplinary approach to management and is associated with significant healthcare and economic cost in later stages of disease. In revisiting how the pandemic transformed guidelines from diagnosis and surveillance to surgical and systemic management of melanoma, we appraise the evidence behind these decisions and their enduring implications.
format	article
author	Andraia R. Li Manuel Valdebran Manuel Valdebran Daniel Y. Reuben
author_facet	Andraia R. Li Manuel Valdebran Manuel Valdebran Daniel Y. Reuben
author_sort	Andraia R. Li
title	Emerging Developments in Management of Melanoma During the COVID-19 Era
title_short	Emerging Developments in Management of Melanoma During the COVID-19 Era
title_full	Emerging Developments in Management of Melanoma During the COVID-19 Era
title_fullStr	Emerging Developments in Management of Melanoma During the COVID-19 Era
title_full_unstemmed	Emerging Developments in Management of Melanoma During the COVID-19 Era
title_sort	emerging developments in management of melanoma during the covid-19 era
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/ab083738755c4270a22fb8449d46d714
work_keys_str_mv	AT andraiarli emergingdevelopmentsinmanagementofmelanomaduringthecovid19era AT manuelvaldebran emergingdevelopmentsinmanagementofmelanomaduringthecovid19era AT manuelvaldebran emergingdevelopmentsinmanagementofmelanomaduringthecovid19era AT danielyreuben emergingdevelopmentsinmanagementofmelanomaduringthecovid19era
_version_	1718442937111543808

Emerging Developments in Management of Melanoma During the COVID-19 Era

Ejemplares similares